1.

MACC1和c-met的表达与NSCLC的临床病理特征联系

Correlation of MACC1 and c-met expression with clinicopathologic characteristics of NSCLC

Variable	n	MACC1+ (%)	χ2	P	c-met+ (%)	χ2	P
Sex			0.666	0.414		0.666	0.414
Male	77	56 (72.7%)			56 (72.7%)
Female	26	21 (80.8%)			21 (80.8%)
Age (year)			0.320	0.571		0.025	0.875
< 60	51	36 (70.6%)			37 (72.5%)
≥60	52	34 (65.4%)			37 (71.2%)
Smoking			1.195	0.274		0.006	0.938
No	42	26 (61.9%)			30 (71.4%)
Yes	61	44 (72.1%)			44 (72.1%)
Pathological type			0.064	0.800		0.604	0.437
Squamous carcinoma	56	30 (53.6%)			42 (75.0%)
Adenocarcinoma	47	24 (51.1%)			32 (68.1%)
Differentiation			5.536	0.019		4.044	0.044
Well and moderate	83	52 (62.7%)			56 (67.5%)
Poor	20	18 (90.0%)			18 (90.0%)
T stage			3.900	0.048		4.260	0.039
T1-T2	78	49 (62.8%)			52 (66.7%)
T3-T4	25	21 (84.0%)			22 (88.0%)
Lymphatic metastasis			4.282	0.039		4.059	0.044
N0	70	43 (61.4%)			46 (65.7%)
N1-N2	33	27 (81.8%)			28 (84.8%)
TNM stages			7.674	0.006		5.042	0.025
Ⅰ+Ⅱ	68	40 (58.8%)			44 (64.7%)
Ⅲ	35	30 (85.7%)			30 (85.7%)